BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2023 8:03:56 AM | Browse: 424 | Download: 1137
 |
Received |
|
2023-01-09 16:28 |
|
Peer-Review Started |
|
2023-01-09 16:30 |
|
First Decision by Editorial Office Director |
|
2023-01-17 07:08 |
|
Return for Revision |
|
2023-01-17 07:08 |
|
Revised |
|
2023-01-31 07:59 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-04-10 04:10 |
|
Second Decision by Editor-in-Chief |
|
2023-04-16 01:12 |
|
Final Decision by Editorial Office Director |
|
2023-04-17 08:51 |
|
Articles in Press |
|
2023-04-17 08:51 |
|
Edit the Manuscript by Language Editor |
|
2023-04-20 03:45 |
|
Typeset the Manuscript |
|
2023-07-05 01:48 |
|
Publish the Manuscript Online |
|
2023-07-13 08:03 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Review |
| Article Title |
Implications of receptor for advanced glycation end products for progression from obesity to diabetes and from diabetes to cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Andrea Garza-Campos, José Roberto Prieto-Correa, José Alfredo Domínguez-Rosales and Zamira Helena Hernández-Nazará |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Founding Proyectos de Impulso a la Investigación |
PIN 2020-I |
|
| Corresponding Author |
Zamira Helena Hernández-Nazará, MD, PhD, N/A, N/A, Departamento de Biología Molecular y Genómica, Instituto de Investigación en Enfermedades Crónico-Degenerativas, Universidad de Guadalajara, Sierra Mojada 950, Col. Independencia C.P. 44350, Guadalajara 44340, Jalisco, Mexico. zamirahelena@yahoo.com.mx |
| Key Words |
Type 2 diabetes; Cancer; Obesity; Advanced glycation end product receptor; Receptor for advanced glycation end products; Glycation end products; Advanced |
| Core Tip |
The receptor for advanced glycation products (RAGE) is involved in every stage of the pathophysiological pathways that lead to the progression of obesity, type 2 diabetes, and cancer. This article provides a focused discussion on the stages of obesity leading to the development of metabolic diseases and provides a broad overview of the contribution of RAGE to the development of diabetes and cancer. |
| Publish Date |
2023-07-13 08:03 |
| Citation |
Garza-Campos A, Prieto-Correa JR, Domínguez-Rosales JA, Hernández-Nazará ZH. Implications of receptor for advanced glycation end products for progression from obesity to diabetes and from diabetes to cancer. World J Diabetes 2023; 14(7): 977-994 |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i7/977.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i7.977 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
